Virtu Financial LLC Aspira Women'S Health Inc. Transaction History

Virtu Financial LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 01, 2023	SELL	$0.32 - $0.58 $1,424 - $2,581	-4,451 Reduced 23.24%	14,699 $5,000
Q4 2022 Feb 15, 2023	BUY	$0.3 - $0.41 $5,745 - $7,851	19,150 New	19,150 $6,000
Q2 2022 Aug 09, 2022	BUY	$0.4 - $1.09 $14,532 - $39,599	36,330 New	36,330 $21,000
Q1 2022 May 17, 2022	SELL	$0.88 - $1.81 $14,073 - $28,947	-15,993 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$1.63 - $3.43 $26,068 - $54,855	15,993 New	15,993 $28,000
Q4 2020 Feb 24, 2021	SELL	$3.0 - $6.71 $43,260 - $96,758	-14,420 Closed	0 $0
Q3 2020 Dec 11, 2020	BUY	$2.54 - $4.56 $36,626 - $65,755	14,420 New	14,420 $44,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.